Select Medical (NYSE:SEM) Issues FY 2024 Earnings Guidance

Select Medical (NYSE:SEM) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 1.960-2.200 for the period, compared to the consensus earnings per share estimate of 2.120. The company issued revenue guidance of $6.9 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion.

Select Medical Stock Down 1.5 %

Shares of SEM traded down $0.59 during mid-day trading on Thursday, reaching $39.17. The company had a trading volume of 1,183,208 shares, compared to its average volume of 610,053. Select Medical has a 52 week low of $21.28 and a 52 week high of $40.50. The company has a market capitalization of $5.09 billion, a price-to-earnings ratio of 18.73, a price-to-earnings-growth ratio of 1.81 and a beta of 1.43. The firm has a 50-day moving average price of $35.62 and a 200 day moving average price of $31.02. The company has a debt-to-equity ratio of 2.30, a quick ratio of 1.22 and a current ratio of 1.22.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, May 2nd. The health services provider reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.55 by $0.22. The company had revenue of $1.79 billion during the quarter, compared to analyst estimates of $1.70 billion. Select Medical had a net margin of 3.97% and a return on equity of 18.11%. On average, sell-side analysts forecast that Select Medical will post 2.19 EPS for the current year.

Wall Street Analyst Weigh In

SEM has been the topic of several recent research reports. Benchmark increased their price objective on shares of Select Medical from $42.00 to $48.00 and gave the stock a buy rating in a research note on Tuesday, July 16th. Royal Bank of Canada increased their price target on shares of Select Medical from $36.00 to $40.00 and gave the stock an outperform rating in a research report on Monday, May 6th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Select Medical currently has an average rating of Moderate Buy and an average price target of $36.50.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.